本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

PTC Therapeutics Inc.

67.93
-0.3800-0.56%
盤後67.930.00000.00%16:10 EST
成交量:102.28萬
成交額:6,893.57萬
市值:53.96億
市盈率:8.80
高:69.24
開:67.86
低:66.10
收:68.31
52周最高:69.88
52周最低:35.95
股本:7,943.81萬
流通股本:6,501.02萬
量比:1.33
換手率:1.57%
股息:- -
股息率:- -
每股收益(TTM):7.72
每股收益(LYR):-4.7276
淨資產收益率:-7740.12%
總資產收益率:23.81%
市淨率:-26.13
市盈率(LYR):-14.37

資料載入中...

2024/04/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/26

重要事件披露

Form 8-K - Current report
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities